Xenomics Pages on BioPortfolio:

BioPortfolio - www.xenomics.com
www.xenomics.com - BioPortfolio. ... Recent Search Terms used to find this page: www.xenomics.com | xenomics . ...
http://www.bioportfolio.com/search/www.xenomics.com.html...

BioPortfolio - xenomics
Xenomics - Entry on Bioportfolio's Biocorporate Database. ... Xenomics Announces Implementation of its First Diagnostic Test for ... Link to this page: Link ...
http://www.bioportfolio.com/search/xenomics.html...

BioPortfolio - Xenomics
Xenomics - Entry on Bioportfolio's Biocorporate Database. ... Xenomics, Inc. is the developer of next-generation molecular diagnostics . ...
http://www.bioportfolio.com/search/Xenomics.html...

BioPortfolio - xenomics 2008
xenomics 2008 - BioPortfolio. ... Recent Search Terms used to find this page: www.xenomics.com | xenomics | xenomics 2008 | xenomics | Transrenal DNA ...
http://www.bioportfolio.com/search/xenomics_2008.html...

BioPortfolio - Xenomics - Profile
Xenomics, Inc. is the developer of next-generation molecular diagnostics ... Xenomics has made continuing progress in its clinical studies in infectious ...
http://www.bioportfolio.com/biocorporate/32627-Xenomics.pdf...

BioPortfolio - Transrenal DNA testing progress and perspectives
Recent Search Terms used to find this page: www.xenomics.com | xenomics | xenomics 2008 | xenomics | Transrenal DNA testing progress and perspectives .
...
http://www.bioportfolio.com/search/Transrenal_DNA_testing__p...

Results from other life science and pharmaceutical sites:

BioSpace - Xenomics Inc. News, Search Jobs, Events
Xenomics Inc. (XNOM) Invited to Present an Update with Respect to Its Transrenal Nucleic Acids Diagnostic Technology at CNAPS-5 Meeting in Moscow 8/23/2007 ...
http://www.biospace.com/company_profile.aspx?CompanyId=39530...

Xenomics Announces Agreement with Ipsogen for Diagnostic Assays of ...
Xenomics has obtained an exclusive license for the discovery and developed a test that detects all known 45 mutations of NPM1 in one reaction. ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...

Xenomics Announces Board Restructuring: Financial News - Yahoo ...
Xenomics Announces Board Restructuring. - MONMOUTH JUNCTION, NJ--(BUSINESS WIRE) --Xenomics, Inc. (the “Company”) (XNOM.
http://biz.yahoo.com/bw/081007/20081007006719.html?.v=1...

Xenomics Announces Implementation of its First Diagnostic Test for ...
Xenomics has obtained an exclusive license for the invention and developed a test that detects all 45 known mutations of NPM1 in a single reaction. ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...

News: Xenomics Appoints Former Bayer Pharmaceuticals CEO and ...
5 Apr 2006 ... Xenomics Appoints Former Bayer Pharmaceuticals CEO and President Colin J. Foster to its Board of Directors; Foster to Bring Product ...
http://www.genengnews.com/news/bnitem.aspx?name=136772...

PR Ipsogen & Xenomics on NPM1
“This agreement with XENOMICS, a leading company developing innovative DNA-based ... Xenomics is a molecular diagnostics company that focuses on the ...
http://www.ipsogen.com/fileadmin/documents/Press_release_fin...

Xenomics Inc. Invited To Present The Transrenal DNA Diagnostic ...
"We were pleased to be invited by the ASM to introduce this breakthrough DNA- based diagnostic technology," said Dr. David Tomei, CEO of Xenomics. ...
http://www.biospace.com/news_story.aspx?NewsEntityId=19789...

Summary of XENOMICS INC - Yahoo! Finance
Subsequent to the approval of the disinterested members of the Board of Directors, on October 30, 2007, Xenomics, Inc. (the "Company") and Gianluigi ...
http://biz.yahoo.com/e/071105/xnom.pk8-k.html...

Xenomics. [Genome Res. 2005] - PubMed Result
Xenomics. Amaya E. The Wellcome Trust/Cancer Research UK Gurdon Institute, University of ... Xenopus genomics, or Xenomics for short, is coming of age. ...
http://www.ncbi.nlm.nih.gov/pubmed/16339366...

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.